Tiletamine Hcl & Zolazepam Hcl)

15 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

3330.0%

Death Rate

Active Ingredients

Tiletamine Hcl & Zolazepam Hcl)

Administration Routes

UnknownIntramuscularIntravenousSubcutaneous

Species Affected

Dog 9

Cat 6

Most Affected Breeds

Dog (unknown) 3

Cat (other) 3

Retriever - Golden 2

Domestic Shorthair 2

Retriever - Labrador 1

Mixed (Dog) 1

Spaniel (unspecified) 1

Bulldog 1

Domestic Longhair 1

Most Reported Reactions

Circling - neurological disorder (see also 'Behavioural disorders') 2

Hernia NOS 2

Surgical site disorder 2

Fever 2

Sudden death 2

Sedation 1

Bradycardia 1

Apnoea 1

Depressed ocular reflex 1

Laboured breathing 1

Loose stool 1

Limb weakness 1

Outcome Breakdown

Recovered/Normal

6 (40.0%)

Ongoing

4 (26.7%)

Died

3 (20.0%)

Euthanized

2 (13.3%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.